China Makes Debut Export of Human-Use Vaccines
Posted on: Sunday, 15 January 2006, 09:00 CST
China makes debut export of human-use vaccines
HANGZHOU, Jan. 14 (Xinhua) -- Live hepatitis A vaccine produced by a biotech producer based in this capital of east China's Zhejiang Province has been given a green light to enter the Indian market, marking a debut export of China-made vaccines.
The hepatitis A vaccines independently developed by Chinese viruologists have been inoculated on 130 million persons in China, which has helped bring down the incident rate of the infectious disease by 20 percent every year in China during the past decade.
The Zhejiang Pukang Biotech Co. said on Saturday that the vaccines with complete domestic intellectual property right were ready for export to India, after they passed human test and the ensuing observation for three years in the country.
Although China announced that it has basically controlled the prevalence of hepatitis A, there are still 1.4 million people found infected with the disease globally.
Vaccines remain the most effective way to curb the spreading of hepatitis diseases. Pukang Biotech is exploring exports of the vaccines to Guatemala and the Philippines.
Source: Xinhua News Agency - CEIS
Related Articles
- China Kangtai Cactus Biotech Signs Cooperative Production Agreement for Patented Cactus-based Low and Zero Nicotine Cigarettes
- China Kangtai Cactus Biotech to Present at the Rodman & Renshaw Annual Global Investment Conference in New York on September 11, 2009
- China Kangtai Cactus Biotech to Launch Patented Cactus-based Low Tar, Low or Zero Nicotine Cigarettes
- China Kangtai Cactus Biotech to Attend Rodman & Renshaw Conference and Meet with Investors in September
- China Kangtai Cactus Biotech Q2 Revenue Up 30% to Record $6.5M; Net Income Up 37% to $1.4M, EPS $0.07
- China Kangtai Cactus Biotech Inc. to Launch Patented Cactus Hog Feed
- China Kangtai Cactus Biotech Retains Hawk Associates for Investor Relations Services
- China Kangtai Cactus Biotech Announces Goal to Expand and Enhance Shareholder Communication
- Vaccines Up to Standard in E. China Vaccine Accident: Test
- Drug Dealer Seized for E. China Vaccine Accident
 |
 |
User Comments (0)
RSS Feeds